Condition
Cytomegalovirus clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Cytomegalovirus clinical trials that are recruiting, at sites in 2 countries (most in United States (3), Cambodia (1)). By phase: Phase 4 (1), Phase 2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Cytomegalovirus clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Community spread of multiple infectious diseases in Cambodia from a One Health perspective | — | Phnom Penh, Phnom Penh | Recruiting | Jan 22, 2026 |
| CytoGam immunoglobulin to prevent late CMV disease after liver or kidney transplant | Phase 4 | Boston, Massachusetts and 1 other locations | Recruiting | May 6, 2025 |
| Using donor T-cells to treat viral infections after stem cell transplantation | Phase 2 | Memphis, Tennessee | Recruiting | Dec 23, 2022 |
| Donor-derived virus-specific T cell therapy for CMV or adenovirus after organ or stem-cell transplant | Early Phase 1 | Columbus, Ohio and 1 other locations | Recruiting | Sep 11, 2018 |
All recruiting trials (4)
-
Community spread of multiple infectious diseases in Cambodia from a One Health perspective
This project will test how common and connected dengue, chikungunya, Zika, Japanese encephalitis, and West Nile infections are among people, animals, and the environment across Cambodia.
-
CytoGam immunoglobulin to prevent late CMV disease after liver or kidney transplant
This trial will try giving monthly CytoGam infusions after standard antiviral pills end to see if it lowers the chance of late CMV disease in high-risk liver, kidney, or combined liver-kidney transplant patients (donor positive, recipient negative).
-
Using donor T-cells to treat viral infections after stem cell transplantation
This study is testing if special immune cells from related donors can help patients who had a stem cell transplant fight off viral infections like CMV and ADV.
-
Donor-derived virus-specific T cell therapy for CMV or adenovirus after organ or stem-cell transplant
This tests donor-derived virus-specific T cells to treat CMV or adenovirus reactivation in people who have had a solid organ or stem-cell transplant.
Related topics
Quick answers
How many Cytomegalovirus clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), Cambodia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.